Cargando…
TDP-43 protein variants as biomarkers in amyotrophic lateral sclerosis
BACKGROUND: TDP-43 aggregates accumulate in individuals affected by amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases, representing potential diagnostic and therapeutic targets. Using an atomic force microscopy based biopanning protocol developed in our lab, we previously isol...
Autores principales: | Williams, Stephanie M., Khan, Galam, Harris, Brent T., Ravits, John, Sierks, Michael R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5264476/ https://www.ncbi.nlm.nih.gov/pubmed/28122516 http://dx.doi.org/10.1186/s12868-017-0334-7 |
Ejemplares similares
-
Isolation and characterization of antibody fragments selective for human FTD brain derived TDP-43 variants
por: Venkataraman, Lalitha, et al.
Publicado: (2020) -
TDP‐43 as structure‐based biomarker in amyotrophic lateral sclerosis
por: Beyer, Léon, et al.
Publicado: (2020) -
TDP-43—The key to understanding amyotrophic lateral sclerosis
por: Xu, Zuoshang, et al.
Publicado: (2014) -
The role of TDP-43 mislocalization in amyotrophic lateral sclerosis
por: Suk, Terry R., et al.
Publicado: (2020) -
Mutant TDP-43 within motor neurons drives disease onset but not progression in amyotrophic lateral sclerosis
por: Ditsworth, Dara, et al.
Publicado: (2017)